Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
10.34
+0.18 (1.77%)
At close: Dec 5, 2025, 4:00 PM EST
10.32
-0.02 (-0.19%)
After-hours: Dec 5, 2025, 5:01 PM EST
Entrada Therapeutics Employees
Entrada Therapeutics had 183 employees as of December 31, 2024. The number of employees increased by 24 or 15.09% compared to the previous year.
Employees
183
Change (1Y)
24
Growth (1Y)
15.09%
Revenue / Employee
$336,175
Profits / Employee
-$565,328
Market Cap
370.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 183 | 24 | 15.09% |
| Dec 31, 2023 | 159 | 29 | 22.31% |
| Dec 31, 2022 | 130 | 16 | 14.04% |
| Dec 31, 2021 | 114 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TRDA News
- 1 day ago - Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - Entrada Therapeutics: Soft Q3 Earnings, But Builds Momentum Toward 2026 Readouts - Seeking Alpha
- 4 weeks ago - Entrada Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Entrada Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Entrada Therapeutics, Inc. - Special Call - Seeking Alpha
- 3 months ago - Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program - GlobeNewsWire
- 4 months ago - Entrada (TRDA) Q2 Revenue Drops 98% - The Motley Fool
- 4 months ago - Entrada Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire